Skip to NavigationSkip to content

News

0
Swiss firm says latest round of cuts to the Cancer Drugs Fund has put its future clinical trials ‘in genuine jeopardy’
0
Deal, originally announced in February, strengthens Pfizer’s hand in injectables and the growing biosimilars market
0
US FDA Grants Breakthrough Therapy Designation for investigational medicine ACE910 for people with haemophilia A with Factor VIII inhibitors
0
NHS sign
NHS England expected to ‘de-list’ more treatments from Cancer Drugs Fund 

Features

cells

Researchers from Carnegie Mellon University describe how a US Department of Defense project could change pharma models for cancer drug R&D